[VRTX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
13-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -43.88%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 8,930,700 7,574,400 6,205,683 4,162,821 3,047,597 2,488,652 1,702,177 31.80%
PBT 4,232,400 2,730,400 3,116,798 1,394,919 600,241 -15,689 -67,366 -
Tax 910,400 388,300 405,151 218,109 -1,486,862 -107,324 16,665 94.73%
NP 3,322,000 2,342,100 2,711,700 1,176,810 2,096,896 263,484 -112,052 -
Tax Rate -21.51% -14.22% -13.00% -15.64% 247.71% - - -
Total Cost 5,608,700 5,232,300 3,493,983 2,986,011 950,701 2,225,168 1,814,229 20.68%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 37.20 30.92 43.70 28.27 68.80 10.59 -6.58 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 12.97 9.09 10.44 4.58 8.25 1.06 -0.46 -
EPS Diluted 12.82 9.01 10.29 4.51 8.09 1.04 -0.46 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.